Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 7
2004 5
2005 2
2006 3
2007 3
2008 4
2009 3
2010 4
2011 4
2012 4
2013 4
2014 4
2015 5
2016 1
2017 3
2018 2
2019 1
2020 4
2021 4
2022 4
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in Mice.
Santos EJ, Akbarali HI, Bow EW, Chambers DR, Gutman ES, Jacobson AE, Kang M, Lee YK, Lutz JA, Rice KC, Sulima A, Negus SS. Santos EJ, et al. Among authors: jacobson ae. J Pharmacol Exp Ther. 2024 Apr 18:JPET-AR-2024-002153. doi: 10.1124/jpet.124.002153. Online ahead of print. J Pharmacol Exp Ther. 2024. PMID: 38637015 Free article.
Enhancing Protective Antibodies against Opioids through Antigen Display on Virus-like Particles.
Shafieichaharberoud F, Lang S, Whalen C, Rivera Quiles C, Purcell L, Talbot C, Wang P, Norton EB, Mazei-Robison M, Sulima A, Jacobson AE, Rice KC, Matyas GR, Huang X. Shafieichaharberoud F, et al. Among authors: jacobson ae. Bioconjug Chem. 2024 Feb 21;35(2):164-173. doi: 10.1021/acs.bioconjchem.3c00415. Epub 2023 Dec 19. Bioconjug Chem. 2024. PMID: 38113481
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacy.
Santos EJ, Nassehi N, Bow EW, Chambers DR, Gutman ES, Jacobson AE, Lutz JA, Marsh SA, Rice KC, Sulima A, Selley DE, Negus SS. Santos EJ, et al. Among authors: jacobson ae. Pharmacol Res Perspect. 2023 Aug;11(4):e01111. doi: 10.1002/prp2.1111. Pharmacol Res Perspect. 2023. PMID: 37381112 Free PMC article.
A Journey through Diastereomeric Space: The Design, Synthesis, In Vitro and In Vivo Pharmacological Activity, and Molecular Modeling of Novel Potent Diastereomeric MOR Agonists and Antagonists.
Chambers DR, Sulima A, Luo D, Prisinzano TE, Goldberg A, Xie B, Shi L, Paronis CA, Bergman J, Nassehi N, Selley DE, Imler GH, Jacobson AE, Rice KC. Chambers DR, et al. Among authors: jacobson ae. Molecules. 2022 Sep 30;27(19):6455. doi: 10.3390/molecules27196455. Molecules. 2022. PMID: 36234992 Free PMC article.
77 results